Kenvue’s stock was heading for a record low as investors express concerns over what President Trump will say regarding the use of acetaminophen — the active ingredient in Tylenol — and the autism epidemic.

Tylenol maker Kenvue is reportedly preparing for a glut of lawsuits after President Donald Trump made a baseless warning that the active ingredient in the drug, acetaminophen, could cause autism. At a press conference Monday, Trump repeatedly urged pregnant women, “Don’t take Tylenol.”

Shares of Kenvue bounced back sharply after a tumble following Trump’s claims about Tylenol use by pregnant women.